Among these TRP family genes, it has been shown previously that TRPV2 in brain tumours (2), TRPV6 in PRAD (27), and TRPC6 in STAD (28) promote tumour progression—which validates our analysis. This evidence concerns the gene TRPV6 and prostate adenocarcinoma.